F. Liu et al. / Tetrahedron 66 (2010) 7112e7118
7117
(relative intensity %) 275 [M]þ (10), 277 [M]þ (10). HRMS (ESI):
calcd for: (C9H10NO2SNaBr) 297.95133, found 297.9510.
neutralized with water-ice/Na2CO3, extracted with dichloro-
methane (ꢂ3). The combined organic phases were dried (MgSO4)
and concentrated in vacuo. Products were isolated by column
chromatography purification (50/50: dichloromethane/petroleum
ether) to give 250 mg of compound 25 as a solid (42%).
To a suspension of K2CO3 (276 mg, 2 mmol) in DMF (5 mL) was
added dropwise substrate 4 (276 mg, 1 mmol). The mixture was
stirred for 15 min and allylbromide (0.094 ml, 1.1 mmol) was
added. The resulting mixture was stirred for 12 h under an N2 at-
mosphere at room temperature and then partitioned between
EtOAc (50 mL) and water (30 mL). The organic phase was separated
and dried, and then the solvent was removed in vacuo. 262 mg
(83%) of product 22 was isolated by column chromatography pu-
rification (dichloromethane). Then, a mixture of substrate 22
(0.34 mmol), morpholine (1 mmol), K3PO4 (0.68 mmol), CuI
4.5.1. Compound 25: 4-bromo-N-(2-fluoropropyl)-benzenesulfona-
mide. 1H NMR (300 MHz, CDCl3, ppm): 1.30 (dd, J¼23.8, 6.3 Hz, 3H,
H-30), 3.12 (m, 2H, H-10), 4.70 (dm, J¼48.9 Hz, 1H, H-20), 5.07 (m, 1H,
NH), 7.66 (d, J¼8.7 Hz, 2H, H-3), 7.73 (d, J¼8.7 Hz, 2H, H-2). 13C NMR
(75 MHz, CDCl3, ppm): 18.5 (d, J¼22 Hz, CH3, C-30), 48.5 (d, J¼21 Hz,
CH2, C-10), 89.5 (d, J¼167 Hz, CH, C-20), 128.2 (C-4), 128.9 (2CH, C-2),
132.9 (2CH, C-3), 139.3 (C-1). 19F {1H} NMR (282 MHz, CDCl3, ppm):
ꢀ180.4. MS (GCT, CIþ): m/z (relative intensity %) 222 [MꢀCH3CHF]þ
(12), 220 [MꢀCH3CHF]þ (18). HRMS (ESI): calcd for:
(C9H11NO2FSBrNa) 317.9576, found 317.9579. Melting point (ꢁC):
101e102.
(0.05 mmol), and L-proline (0.1 mmol) in 0.2 mL of DMSO was
heated at 90 ꢁC for 24 h. The cooled mixture was partitioned be-
tween water and ethyl acetate. The organic layer was separated,
and the aqueous layer was extracted with ethyl acetate. The com-
bined organic layers were washed with H2O, dried over MgSO4, and
concentrated in vacuo. Purification of the residual oil by flash col-
umn chromatography (100%, dichloromethane) gave 77 mg of
compound 23 as a colorless oil (70%).
To a suspension of K2CO3 (138 mg, 1 mmol) in DMF (2 mL) was
added dropwise 25 (148 mg, 0.5 mmol). The mixture was stirred for
15 min and CH3I (0.035 ml, 0.55 mmol) was added. The resulting
mixture was stirred for 8 h under an N2 atmosphere and then
partitioned between EtOAc (50 mL) and water (30 mL). The organic
phase was separated and dried, then the solvent was removed in
vacuo, and 154 mg of the desired compound 26 was obtained as
a solid (>95%). Then, a mixture of substrate 26 (0.34 mmol), mor-
pholine (1 mmol), K3PO4 (0.68 mmol), CuI (0.05 mmol), and
4.4.2. Compound 23: 2-allyl-4-methyl-6-morpholin-4-yl-3,4-dihy-
dro-2H-benzo[1,2] thiazine 1,1-dioxide. 1H NMR (400 MHz, CDCl3,
ppm): 1.29 (d, J¼7.2 Hz, 3H, CH3), 3.10 (m, 1H, H-4), 3.20 (t,
J¼4.8 Hz, 4H, H-30), 3.53 (m, 3H, H-3, and H-200), 3.80 (t, J¼4.8 Hz,
4H, H-20), 3.99 (dd, J¼14.4, 5.2 Hz, 1H, H-200), 5.25 (m, 2H, H-400),
5.80 (s, 1H, H-300), 6.68 (d, J¼2.0 Hz, 1H, H-5), 6.81 (dd, J¼8.8, 2.4 Hz,
1H, H-7), 7.63 (d, J¼8.8 Hz, 1H, H-8). 13C NMR (100 MHz, CDCl3,
ppm): 19.4 (CH3), 29.1 (CH, C-4), 47.9 (2CH2, C-30), 49.9 (CH2, C-30),
51.2 (CH2, C-3), 66.6 (2CH2, C-20), 112.9 (CH, C-5), 113.4 (CH, C-7),
119.5 (CH, C-400), 125.8 (CH, C-8), 126.4 (C-9), 132.9 (CH, C-300), 141.6
(C-6), 153.6 (C-10). MS (GCT, CIþ): m/z (relative intensity %) 345
[MþNa]þ (100). HRMS (ESI): calcd for: (C16H22N2O3NaS) 345.1248,
found 345.1248.
L
-proline (0.1 mmol) in 0.2 mL of DMSO was heated at 90 ꢁC for
24 h. The cooled mixture was partitioned between water and ethyl
acetate. The organic layer was separated, and the aqueous layer was
extracted with ethyl acetate. The combined organic layers were
washed with H2O, dried over MgSO4, and concentrated in vacuo.
The residual oil was loaded on a silica gel column. Purification by
flash column chromatography (100%, dichloromethane) gave
66 mg of compound 9 as a solid (61%).
To a mixture of HF/SbF5 (3 mL, 7/1 M ratio) maintained at ꢀ20 ꢁC
for 10 min, was added substrate 23 (1 mmol). The mixture was
magnetically stirred at the same temperature for reaction time. The
reaction mixture was then neutralized with water-ice/Na2CO3,
extracted with dichloromethane (ꢂ3). The combined organic phases
were dried (MgSO4) and concentrated in vacuo. Products were iso-
lated by column chromatography purification (40/60, ethyl acetate/
petroleum ether) and 236 mg of the compound 24 was obtained as
a colorless oil (69%).
4.5.2. Compound 9: N-(2-fluoro-propyl)-N-methyl-4-morpholin-4-
yl-benzenesulfonamide. 1H NMR (400 MHz, CDCl3, ppm): 1.35 (dd,
J¼23.6, 6.4 Hz, 3H, H-30), 2.79 (s, 3H, NCH3), 3.14 (m, 6H, H-10, and H-
200), 3.84 (t, J¼4.8 Hz, 4H, H-300), 4.83 (dm, J¼48.8 Hz, 1H, H-20), 6.89
(d, J¼9.2 Hz, 2H, H-3), 7.72 (d, J¼9.2 Hz, 2H, H-2). 13C NMR (100 MHz,
CDCl3, ppm): 18.4 (d, J¼22 Hz, CH3, C-30), 36.7 (d, J¼3 Hz, NCH3), 47.5
(s, 2CH2, C-200), 54.9 (d, J¼22 Hz, CH2, C-10), 66.5 (s, 2CH2, C-300), 90.3
(d, J¼168 Hz, CH, C-20), 113.8 (s, 2CH, C-3), 126.5 (s, C-1), 129.1 (s,
2CH, C-2), 153.8 (s, C-4). 19F {1H} NMR (282 MHz, CDCl3, ppm):
ꢀ179.7. MS (GCT, CIþ): m/z (relative intensity %) 339 [MþNa]þ (100),
317 [M]þ (65). HRMS (ESI): calcd for: (C14H21N2O3FNaS) 339.1154,
found 339.1156. Melting point (ꢁC): 103e104.
4.4.3. Compound 24: 2-(2-fluoro-propyl)-4-methyl-6-morpholin-4-yl-
3,4-dihydro-2H-benzo[1,2] thiazine 1,1-dioxide. 1H NMR (400 MHz,
CDCl3, ppm): 1.37 (m, 6H, CH3, and H-300), 3.12 (m, 1H, H-4), 3.23 (t,
J¼5.2 Hz, 4H, H-30), 3.57 (m, 4H, H-100, and H-3), 3.84 (t, J¼4.8 Hz,
4H, H-20), 4.90 (dm, J¼48.4 Hz, 1H, H-200), 6.70 (s, 1H, H-5), 6.82
(dd, J¼8.8, 2.0 Hz, 1H, H-7), 7.67 (d, J¼8.8 Hz, 1H, H-8). 13C NMR
(100 MHz, CDCl3, ppm): 18.0 and 18.6 (2d, J¼22 Hz, C-300), 19.1 and
19.3 (CH3), 29.1 and 29.6 (CH, C-4), 47.9 (s, 2CH2, C-30), 51.9 and
52.0 (2d, J¼21 Hz, CH2, C-100), 54.1 and 54.3 (CH2, C-3), 66.5 (s,
2CH2, C-20), 90.3 and 91.4 (2d, J¼168 Hz, CH, C-200), 112.9 (s, CH, C-
5), 113.3 (CH, C-7), 125.7 and 125.8 (CH, C-8), 126.3 and 126.6 (C-9),
141.6 and 141.7 (C-6), 153.6 (s, C-10). 19F {1H} NMR (282 MHz,
CDCl3, ppm): ꢀ179.4. MS (GCT, CIþ): m/z (relative intensity %) 365
[MþNa]þ (100). HRMS (ESI): calcd for: (C16H23N2O3FNaS) 365.1311,
found 365.1311.
Acknowledgements
We thank the region Poitou-Charentes (grant to F.L.), the CNRS,
and the University of Poitiers for financial support.
Supplementary data
Experimental procedures, products characterization and copies
of NMR spectra. Supplementary data associated with this article
4.5. Synthesis of product 9
References and notes
To a mixture of HF/SbF5 (3 mL, 7/1 M ratio) maintained at ꢀ20 ꢁC
for 10 min, was added N-allyl-4-bromobenzene sulfonamide
(2 mmol). The mixture was magnetically stirred at the same tem-
perature for reaction time. The reaction mixture was then
1. Antimicrobial Agents: Antibacterials and Antifungals; Bryskier, A., Ed.; ASM:
Washington, 2005.
2. Cheng, X.-C.; Wang, Q.; Fang, H.; Xu, W.-F. Curr. Med. Chem. 2008, 15, 368e373.
3. (a) Supuran, C. T. Nat. Rev. Drug. Discov. 2008, 7, 168e181; (b) Winum, J.-Y.; Rami,
M.; Scozzafava, A.; Montero, J.-L.; Supuran, C. Med. Res. Rev. 2008, 28, 445e463.